Holland & Knight Health Dose: February 7, 2023
![Holland & Knight Health Dose](/-/media/images/twittercards/blogs/healthdose.png?rev=28e9e198d69c446c9fd8409f368b8252&sc_lang=en&hash=7A2FDB35CB2B5C08E70E64C1347FE915)
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
- President Biden to Release Budget on March 9
-
Energy and Commerce Committee Addresses the Use of QALYs
-
Wyden Presses CMS for Details on Drug Pricing Law Implementation
-
COVID-19 Emergency Declarations End on May 11
-
CMS Releases Advance Notice of Methodological Changes For 2024 MA, Part D Payment Policies
-
FTC Signals Increased Enforcement for Unauthorized Health Data Sharing
-
CMS Releases Guidance on Changes to Medicaid Continuous Enrollment Requirement
-
340B Contract Pharmacy Limits